GLPwatch
Trials (2167)
Page 22 of 37.
- A Research Study Looking at How Oral Semaglutide Works in People With Type 2 Diabetes in Canada, as Part of Local Clinical Practice
- A Study of IBI362 in Chinese Patients With Type 2 Diabetes
- Gut Derived Hormones, Body Composition and Metabolism in Prader-Willi Syndrome
- Influence of JY09 on Pharmacokinetics of Metformin , Rosuvastatin , and Digoxin and the QT Interval Study in Overweight Chinese Subjects
- Body Composition and Exercise to Prevent Muscle Loss With GLP1 Agonist Treatment
- Phase 2 Clinical Study of MWN109 Tablets in Participants With Type 2 Diabetes Mellitus
- A Clinical Trial Investigating the Comparison of Three Different Concentrations of NN9535 in Healthy Male Subjects
- A Research Study to Compare Blood Levels of Cagrilintide and Semaglutide After Combined Versus Separate Injections in People With Overweight or Obesity
- Optimizing Portal Hypertension With TIPS and Interval Metabolic Surgery for Advanced Liver Disease
- The Effect of Liraglutide on Left Ventricular Function in Chronic Heart Failure Patients With and Without Type 2 Diabetes Mellitus
- Comparison of the Efficacy and Safety of SGLT2i and GLP-1 Receptor Agonists in Obese Patients With Kidney Disease
- Use of Continuous Glucose Monitoring Combined With Ambulatory Glucose Profiles to Characterize Glycemic Control
- Study of ITCA 650 (Exenatide in DUROS) in Subjects With Type 2 Diabetes Mellitus
- GLP-1 Receptor Agonist Lixisenatide in Patients With Type 2 Diabetes for Glycemic Control and Safety Evaluation, on Top of Pioglitazone
- GLP-1 Receptor Targeting in Diabetic and Healthy Individuals
- Tirzepatide in the Treatment of Endometrial Cancer
- The Effects of Semaglutide on Body Composition and Performance in Military Personnel
- Treatment of Hypoglycemia Following Gastric Bypass Surgery
- Obstructive Sleep Apnea Master Protocol GPIF: A Study of Tirzepatide (LY3298176) in Participants With Obstructive Sleep Apnea
- Semaglutide Therapy for Alcohol Reduction (STAR)
- The Effect of an Anti-obesity Drug, Semaglutide, as Treatment in New-onset Idiopathic Intracranial Hypertension (IIH) Compared to Standard Weight Management (Dietician) With Regards to Change in Weight and Intracranial Pressure
- Efficacy in Controlling Glycaemia With Victoza® (Liraglutide) as add-on to Metformin vs. OADs as add-on to Metformin After up to 104 Weeks of Treatment in Subjects With Type 2 Diabetes
- Non-Alcoholic Fatty Liver Disease, the HEpatic Response to Oral Glucose, and the Effect of Semaglutide (NAFLD HEROES)
- The Ameliorative Effects of GLP-1RA on Diabetic Cardiac Autonomatic Neuropathy
- A Study of Dulaglutide in Healthy Participants
- A Regulatory Post-marketing Surveillance (rPMS) Study to Evaluate the Safety and Effectiveness of Saxenda®(Liraglutide 3.0 mg) in Obese Patients and Overweight Patients With Obesity-related Comorbidities in Routine Clinical Practice in Korea.
- Comparative Study of Tirzepatide Versus Dulaglutide (SURPASS CVOT) or Semaglutide on Major Cardiovascular Events in Participants With Type 2 Diabetes
- Effects of Tirzepatide on Weight Loss and Chronic Inflammation in People With HIV
- Exenatide Once Weekly, Cardiovascular Risk and Type-2 Diabetes
- Effects of Exenatide on Motor Function and the Brain
- A Research Study to Compare a Medicine Called Semaglutide Against Placebo in People With Peripheral Arterial Disease and Type 2 Diabetes
- Tirzepatide in MetALD
- A Study of Retatrutide (LY3437943) in Participants With Obesity or Overweight
- Comprehensive Clinical Evaluation Study of GLP-1RA
- A Clinical Study of Efinopegdutide in Participants With Precirrhotic Nonalcoholic Steatohepatitis (NASH) (MK-6024-013)
- The Effect of Combined Dulaglutide and Dapagliflozin Treatment vs DPP-4 Inhibitors in Endothelial and Vascular Function in Patients With Type 2 Diabetes Mellitus and Albuminuria
- HbA1c Variability in Type II Diabetes
- Phase 1/2a Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Effect on Body Weight of RN3161 as Monotherapy and in Combination With Tirzepatide in Adults With Overweight and Obesity
- A Study of Tirzepatide (LY3298176) in Participants With Obesity or Overweight With Weight Related Comorbidities
- Semaglutide's Weight Loss Effects in Obesity
- SEMAGLUTIDE VERSUS GLP-1 RECEPTOR AGONISTS. EFFECTIVENESS , SAFETY AND QUALITY OF LIFE IN PATIENTS WITH DIABETES MELLITUS 2. OBSERVATIONAL, PROSPECTIVE AND MULTICENTER STUDY. SEVERAL STUDY.
- Effect of GLP1 Receptor Agonist on Brain Insulin Responsiveness
- Liraglutide as Add on Therapy on Metformin in Women With Polycystic Ovary Syndrome
- Pilot Study of the Effect of Liraglutide on Weight Loss and Gastric Functions in Obesity
- SAFEGUARD: Pleiotropic Effects of Incretin Based Therapies
- A Study of Tirzepatide (LY3298176) Versus Semaglutide Once Weekly as Add-on Therapy to Metformin in Participants With Type 2 Diabetes
- Treatment of GLP-1 for Diabetic Bariatric Patients
- Dapagliflozin As Additional Treatment To Liraglutide And Insulin In Patients With Type 1 Diabetes
- Investigation of Optimal Dosing Conditions for a Long Acting GLP-1 Analogue in Healthy Male Subjects
- A Clinical Trial to Examine the Efficacy and Safety of an Investigational Product With and Without Use of Semaglutide on Glycemic Response in Adults With Prediabetes or Type 2 Diabetes
- A Study of BGM0504 in Participants With Obesity
- GLP1R Polymorphisms and Response to GLP1
- Pharmacokinetic Similarity, Safety, and Immunogenicity of Semaglutide Injection and Ozempic ® Injection in Healthy Subjects.
- New Imaging Procedure for the Localisation of Insulinoma
- Phase III Clinical Study Comparing the Efficacy and Safety of GZR18 Injection and Semaglutide (Wegovy®) in Adult Obese or Overweight Subjects
- A Study to See How Metabolism is Influenced by Weight Loss Due to Intervention With Cagrilintide and Semaglutide Compared to Diet
- A Trial of Oral VRB-103 Alone or in Combination With Oral Ecnoglutide (VRB-101) in Participants With Obesity or Overweight
- Evaluation of Cardiovascular Outcomes in Patients With Type 2 Diabetes After Acute Coronary Syndrome During Treatment With AVE0010 (Lixisenatide)
- Effects of Liraglutide on Body Surface Gastric Mapping
- A Pilot Study of Effects of Exenatide on Body Weight in Non-Diabetic, Obese Patients